首页 | 本学科首页   官方微博 | 高级检索  
     

南瓜蛋白对人胰腺癌细胞系PANC-1的细胞毒性及化疗增敏作用
引用本文:许春森,黄鹤光,陈明晃,魏香兰,何莉,陈燕卿,谢捷明. 南瓜蛋白对人胰腺癌细胞系PANC-1的细胞毒性及化疗增敏作用[J]. 中国普通外科杂志, 2009, 18(3): 7-236
作者姓名:许春森  黄鹤光  陈明晃  魏香兰  何莉  陈燕卿  谢捷明
作者单位:(1.福建医科大学附属协和医院 普通外科, 福建 福州 350001; 2.中国科学院福建物质结构研究所 结构化学国家重点实验室, 福建 福州 350002; 3.福建医科大学药学院 药学系, 福建 福州 350001)
基金项目:国家自然科学基金(项目编号:30772587),福建省自然科学基金(项目编号:C0510012)
摘    要:目的:观察南瓜蛋白(CUS)对人胰腺癌细胞系PANC-1的细胞毒性和化疗增敏作用。方法:采用四甲基偶氮唑蓝(MTT)比色法,观察不同浓度(量效)的CUS及作用不同时间(时效)对胰腺癌细胞PANC-1的细胞毒性;采用 Chou Talalay 联合指数法判断CUS增加胰腺癌细胞对吉西他滨(GEM)的化疗敏感性。结果:CUS对胰腺癌PANC-1细胞具有显著的增殖抑制作用,0.3125, 0.625, 1.25, 2.5, 5.0, 10.0, 20.0, 40.0, 80.0 μg/mL的CUS作用于胰腺癌细胞24 h,其抑制率分别为9.16%,11.9%,14.4%,20.2%,32.0%,36.4%,44.1%,50.3%和58.6%,呈现明显的剂量依赖性;随着作用时间的延长,其抑制率明显增加, 24,48,72 h的半数抑制浓度(IC 50)分别为40.24,8.24,1.17 μg/mL,呈现明显的时间依赖性。两药在不同效应时各自所需浓度之间相互作用均为协同作用(CI<1), 单吉西他滨用于胰腺癌细胞的IC 50为36.76 nmol/L, CUS与其合用时的IC 50为12.14 nmol/L,合用比单用时吉西他滨的剂量减少67.0%。结论:CUS对胰腺癌的细胞毒性作用呈明显的剂量依赖性和时间依赖性,与吉西他滨联合使用可增加其细胞毒作用,起到化疗增敏效应。

关 键 词:胰腺肿瘤/药物疗法; 南瓜蛋白; 吉西他滨; 化疗增敏
收稿时间:1900-01-01
修稿时间:1900-01-01

Cytotoxic and chemo-sensitivity enhancement effect of cucurmosin on pancreatic cancer cell line PANC-1 in vitro
XU Chunsen,HUANG Heguang,CHEN Minghuang,WEI Xianglan,HE Li,CHEN Yanqing,XIE Jieming. Cytotoxic and chemo-sensitivity enhancement effect of cucurmosin on pancreatic cancer cell line PANC-1 in vitro[J]. Chinese Journal of General Surgery, 2009, 18(3): 7-236
Authors:XU Chunsen  HUANG Heguang  CHEN Minghuang  WEI Xianglan  HE Li  CHEN Yanqing  XIE Jieming
Affiliation:(1.Department of General Surgery, Union Hospital,Fujian Medical University, Fuzhou 350001,China;2. State Key Laboratory of structure Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Science, Fuzhou 350002, China;3.School of Pharmacy, Fujian Medical University, Fuzhou 350001,China)
Abstract:Objective:To investigate the cytotoxic and chemo-sensitivity enhamcement effect of cucurmosin(CUS) on pancreatic cancer cell line PANC-1 in vitro.Methods:The cytotoxic effect of the different concentrations of CUS on PANC-1 cells in different time periods (24, 48 and 72 hours) was detected by means of MTT assay,and the chemo-sensitivity enhancement effect of CUS on gemcitabine(GEM) was evaluated by combination-index method of Chou and Talalay.Results:Cucurmosin significantly inhibited the proliferation of pancreatic cancer cell line PANC-1 in dosage-and time-dependent manner. After exposure to 0.3125,0.625,1.25,2.5,5.0,10.0,20.0,40.0 and 80 μg/mL of CUS, the inhibitory rate of the cell growth at 24 hours was 9.16%,11.9%,14.4%,20.2%,32.0%,36.4%,44.1%,50.3%and 58.6%respectively. The 50% inhibitory concentration (IC 50) at 24、48 and 72 h was 40.24 μg/mL,8.24 μg/mL and 1.17 μg/mL respectively. The combination of CUS and GEM at different concentrations showed synergic effect on inhibiting PNCA-1 cell growth (CI<1).The 50% inhibitory concentration (IC 50) of GEM decreased from 36.76 nmol/L to 12.14 nmol/L(less than 67.0%) when combined with CUS.Conclusions:Cucurmosin can significantly inhibit the proliferation of PANC-1 cells in dosage-and time-dependent manner in vitro,and combination with gemcitabine increases its cytotoxic action and provides chemo-sensitivity enhancement effect on pancreatic cancer cell line PANC-1.
Keywords:Pancreatic Neoplasms/drug ther   Cucurmosin   Gemcitabine   Chemo-sensitization
点击此处可从《中国普通外科杂志》浏览原始摘要信息
点击此处可从《中国普通外科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号